You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

ACYCLOVIR SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Acyclovir Sodium patents expire, and when can generic versions of Acyclovir Sodium launch?

Acyclovir Sodium is a drug marketed by Apothecon, Chartwell Injectable, Dr Reddys, Eugia Pharma, Eurohlth Intl Sarl, Fresenius Kabi Usa, Hikma, Hospira, Norvium Bioscience, Slate Run Pharma, Teva Parenteral, and Zydus Pharms. and is included in nineteen NDAs.

The generic ingredient in ACYCLOVIR SODIUM is acyclovir sodium. There are fifty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Acyclovir Sodium

A generic version of ACYCLOVIR SODIUM was approved as acyclovir sodium by FRESENIUS KABI USA on May 13th, 1998.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ACYCLOVIR SODIUM?
  • What are the global sales for ACYCLOVIR SODIUM?
  • What is Average Wholesale Price for ACYCLOVIR SODIUM?
Drug patent expirations by year for ACYCLOVIR SODIUM
Drug Prices for ACYCLOVIR SODIUM

See drug prices for ACYCLOVIR SODIUM

Recent Clinical Trials for ACYCLOVIR SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sohag UniversityPhase 4
Haining Health-Coming Biotech Co., Ltd.Phase 2
Alphacait, LLCPhase 2

See all ACYCLOVIR SODIUM clinical trials

US Patents and Regulatory Information for ACYCLOVIR SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms ACYCLOVIR SODIUM acyclovir sodium INJECTABLE;INJECTION 206606-001 Jun 13, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apothecon ACYCLOVIR SODIUM acyclovir sodium INJECTABLE;INJECTION 074897-002 Feb 27, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira ACYCLOVIR SODIUM acyclovir sodium INJECTABLE;INJECTION 074663-001 Apr 22, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Parenteral ACYCLOVIR SODIUM acyclovir sodium INJECTABLE;INJECTION 075627-001 Mar 28, 2001 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eurohlth Intl Sarl ACYCLOVIR SODIUM acyclovir sodium INJECTABLE;INJECTION 074913-002 Oct 15, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Injectable ACYCLOVIR SODIUM acyclovir sodium INJECTABLE;INJECTION 074596-002 Apr 22, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma ACYCLOVIR SODIUM acyclovir sodium INJECTABLE;INJECTION 205771-002 Feb 29, 2016 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.